Last reviewed · How we verify

NCT05272670

Digital Foot Self-Management Program for Older-Diabetes

Status unknown NA Last updated 7 July 2022
What this trial tests

NA trial testing A digital foot self-management program in Diabetes Mellitus in 100 participants. Status unknown.

Timeline
15 February 2022
Primary endpoint
31 August 2022
31 August 2022

Quick facts

Lead sponsorFooyin University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment100
Start date15 February 2022
Primary completion31 August 2022
Estimated completion31 August 2022
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Fooyin University

Who can join

Adults 65 to 85, any sex, with Diabetes Mellitus or Type 2 Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aims of this proposed study are to evaluate the effect of a digital foot self-management program on the primary outcome of self-efficacy, and secondary outcomes of self-care behaviors, HbA1c and health promotion satisfaction for older adults with type 2 diabetes.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Investigating the effects of digital foot self-management program on enhancing self-efficacy and self-care behavior among community-dwelling older adults with type 2 diabetes: A randomized controlled trial.
    Chen SM, Jo Wu CJ. · · 2023 · cited 6× · PMID 38107978 · DOI 10.1177/20552076231220791

Verify or expand the search:

Other recruiting trials for Diabetes Mellitus

Currently open trials in the same condition.

Other Fooyin University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05272670.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing